Found: 5000
Select item for more details and to access through your institution.
Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment.
- Published in:
- Archives of Dermatological Research, 2025, v. 317, n. 1, p. 1, doi. 10.1007/s00403-024-03688-5
- By:
- Publication type:
- Article
Therapeutic Effect of Mesenchymal Stem Cells and Olive Leaf Extract Against Cytotoxicity Induced by Streptozotocin in Gestational Diabetes Rats.
- Published in:
- Cellular Physiology & Biochemistry (Cell Physiol Biochem Press GmbH & Co. KG), 2024, v. 58, n. 6, p. 702, doi. 10.33594/000000744
- By:
- Publication type:
- Article
Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'".
- Published in:
- Journal of the Endocrine Society, 2025, v. 9, n. 1, p. 1, doi. 10.1210/jendso/bvae218
- By:
- Publication type:
- Article
Letter to Editor From Ishaq MU et al: "Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease".
- Published in:
- Journal of the Endocrine Society, 2025, v. 9, n. 1, p. 1, doi. 10.1210/jendso/bvae217
- By:
- Publication type:
- Article
Satiety Hormone LEAP2 After Low-Calorie Diet With/Without Endobarrier Insertion in Obesity and Type 2 Diabetes Mellitus.
- Published in:
- Journal of the Endocrine Society, 2025, v. 9, n. 1, p. 1, doi. 10.1210/jendso/bvae214
- By:
- Publication type:
- Article
Copper Deficiency Associated with Glycemic Control in Individuals with Type 2 Diabetes Mellitus.
- Published in:
- Biological Trace Element Research, 2025, v. 203, n. 1, p. 119, doi. 10.1007/s12011-024-04185-6
- By:
- Publication type:
- Article
Medication refills do not guarantee medication intake: translation and validation of the Adherence to Refills and Medications Scale in Traditional Chinese among individuals with type 2 diabetes in Taiwan.
- Published in:
- Postgraduate Medicine, 2025, v. 137, n. 1, p. 68, doi. 10.1080/00325481.2024.2444258
- By:
- Publication type:
- Article
Statement of Retraction: The interaction between insulin resistance and Alzheimer's disease: a review article.
- Published in:
- Postgraduate Medicine, 2025, v. 137, n. 1, p. 108, doi. 10.1080/00325481.2024.2436247
- Publication type:
- Article
Histopathological Evaluation of the Effects of Pistacia atlantica Extract on a Mouse Model of Diabetic Wound.
- Published in:
- Anatomical Sciences Journal, 2023, v. 20, n. 1, p. 1
- By:
- Publication type:
- Article
Shenlian Decoction Ameliorates LPS‐Related Inflammation in db/db Mice: Coupling Network Pharmacology With Experimental Verification.
- Published in:
- Journal of Diabetes Research, 2025, v. 2025, p. 1, doi. 10.1155/jdr/3823051
- By:
- Publication type:
- Article
Alcohol Use Disorder in Patients with Chronic Migraine: A Retrospective, Observational Study.
- Published in:
- Canadian Journal of Neurological Sciences, 2024, v. 51, n. 6, p. 767, doi. 10.1017/cjn.2024.10
- By:
- Publication type:
- Article
Type 2 diabetes prediction method based on dual-teacher knowledge distillation and feature enhancement.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-83902-6
- By:
- Publication type:
- Article
Effect of empagliflozin on weight in patients with prediabetes and diabetes.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-83820-7
- By:
- Publication type:
- Article
A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-81747-7
- By:
- Publication type:
- Article
Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-75461-7
- By:
- Publication type:
- Article
Cell-free supernatant of Levilactobacillus brevis (RAMULAB51) from coconut inflorescence sap (Neera) enhances glucose uptake and PPAR-γ in 3T3-L1 adipocytes and inhibits α-glucosidase and α-amylase.
- Published in:
- Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2024.1497023
- By:
- Publication type:
- Article
Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 953, doi. 10.1111/dom.16095
- By:
- Publication type:
- Article
Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 944, doi. 10.1111/dom.16094
- By:
- Publication type:
- Article
The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 885, doi. 10.1111/dom.16089
- By:
- Publication type:
- Article
Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 866, doi. 10.1111/dom.16087
- By:
- Publication type:
- Article
Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 856, doi. 10.1111/dom.16086
- By:
- Publication type:
- Article
Three decades of glucose‐lowering therapy in patients at high cardiovascular risk — A real‐world analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 835, doi. 10.1111/dom.16084
- By:
- Publication type:
- Article
Correction to "Real‐world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus".
- Published in:
- 2025
- Publication type:
- Correction Notice
Glycaemic response to pasta from three different wheat varieties in individuals with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1014, doi. 10.1111/dom.16082
- By:
- Publication type:
- Article
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 806, doi. 10.1111/dom.16078
- By:
- Publication type:
- Article
Early combination therapy with SGLT2i and GLP‐1 RA or dual GIP/GLP‐1 RA in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 468, doi. 10.1111/dom.16077
- By:
- Publication type:
- Article
Glucagon‐like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1005, doi. 10.1111/dom.16076
- By:
- Publication type:
- Article
Treatment persistence, adherence and healthcare resource utilisation for iGlarLixi versus basal–bolus insulin or premixed insulin in older adult ethnic minorities with type 2 diabetes: SoliEthnicity study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 795, doi. 10.1111/dom.16075
- By:
- Publication type:
- Article
Relationship between trajectory of Chinese visceral adiposity index and risk of type 2 diabetes mellitus: Evidence from the China‐PAR project.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 785, doi. 10.1111/dom.16074
- By:
- Publication type:
- Article
Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 777, doi. 10.1111/dom.16073
- By:
- Publication type:
- Article
Incidence of diabetes mellitus following hospitalisation for COVID‐19 in the United Kingdom: A prospective observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 767, doi. 10.1111/dom.16071
- By:
- Publication type:
- Article
Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 447, doi. 10.1111/dom.16070
- By:
- Publication type:
- Article
Effectiveness and cost‐effectiveness of an app and rewards‐based intervention in type 2 diabetes: A randomised controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 729, doi. 10.1111/dom.16067
- By:
- Publication type:
- Article
Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 719, doi. 10.1111/dom.16066
- By:
- Publication type:
- Article
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 710, doi. 10.1111/dom.16065
- By:
- Publication type:
- Article
Targeting the cholinergic anti‐inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 675, doi. 10.1111/dom.16060
- By:
- Publication type:
- Article
The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes‐related and cancer outcomes.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 663, doi. 10.1111/dom.16059
- By:
- Publication type:
- Article
Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 652, doi. 10.1111/dom.16058
- By:
- Publication type:
- Article
De‐intensification of basal‐bolus therapy by replacing prandial insulin with once‐weekly subcutaneous semaglutide in individuals with well‐controlled type 2 diabetes: A single‐centre, open‐label randomised trial (TRANSITION‐T2D)
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 642, doi. 10.1111/dom.16057
- By:
- Publication type:
- Article
Effect of smoking behaviour and related blood DNA methylation on visceral adipose tissues.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 619, doi. 10.1111/dom.16054
- By:
- Publication type:
- Article
Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 583, doi. 10.1111/dom.16050
- By:
- Publication type:
- Article
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 574, doi. 10.1111/dom.16049
- By:
- Publication type:
- Article
Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 563, doi. 10.1111/dom.16048
- By:
- Publication type:
- Article
Non‐clinical and first‐in‐human characterization of ECC5004/AZD5004, a novel once‐daily, oral small‐molecule GLP‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 551, doi. 10.1111/dom.16047
- By:
- Publication type:
- Article
Association and mediation pathways of maternal hyperglycaemia and liability to gestational diabetes with neonatal outcomes: A two‐sample Mendelian randomization study.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 529, doi. 10.1111/dom.16045
- By:
- Publication type:
- Article
The cellular and molecular mechanisms mediating the protective effects of sodium–glucose linked transporter 2 inhibitors against metabolic dysfunction‐associated fatty liver disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 457, doi. 10.1111/dom.16043
- By:
- Publication type:
- Article
Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 519, doi. 10.1111/dom.16042
- By:
- Publication type:
- Article
The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 511, doi. 10.1111/dom.16041
- By:
- Publication type:
- Article
Prolonged exposure to insulin might cause epigenetic alteration leading to insulin resistance.
- Published in:
- FEBS Open Bio, 2025, v. 15, n. 1, p. 81, doi. 10.1002/2211-5463.13891
- By:
- Publication type:
- Article
Pregnancy and Diabetes.
- Published in:
- Nepal Journal of Obstetrics & Gynaecology, 2024, v. 19, n. 1, p. 59
- By:
- Publication type:
- Article